Your browser doesn't support javascript.
loading
Cost Effectiveness of New Diagnostic Tools for Cutaneous Leishmaniasis in Afghanistan.
Aerts, Céline; Vink, Martijn; Pashtoon, Sayed Jalal; Nahzat, Sami; Picado, Albert; Cruz, Israel; Sicuri, Elisa.
Affiliation
  • Aerts C; ISGlobal, Hospital-Clínic-Universitat de Barcelona, Carrer Rosselló 132, 08036, Barcelona, Spain. celine.aerts@isglobal.org.
  • Vink M; Health Works (Formerly HealthNet TPO), Amsterdam, The Netherlands.
  • Pashtoon SJ; Health Works (Formerly HealthNet TPO), Kabul, Afghanistan.
  • Nahzat S; National Malaria and Leishmaniasis Control Program, Ministry of Public Health, Kabul, Afghanistan.
  • Picado A; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Cruz I; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Sicuri E; ISGlobal, Hospital-Clínic-Universitat de Barcelona, Carrer Rosselló 132, 08036, Barcelona, Spain.
Appl Health Econ Health Policy ; 17(2): 213-230, 2019 04.
Article in En | MEDLINE | ID: mdl-30465319
BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis is responsible for chronic and disfiguring skin lesions resulting in morbidity and social stigma. The gold standard to diagnose cutaneous leishmaniasis is microscopy but has a variable sensitivity and requires trained personnel. Using four scenarios, the objective of this study is to compare the cost effectiveness of microscopy with two new tools: Loopamp™ Leishmania Detection Kit (LAMP) and CL Detect™ Rapid Test (RDT). METHODS: Data related to the cost and accuracy of these tools were collected at the clinic of the National Malaria and Leishmaniasis Control Program in Kabul, Afghanistan. The effectiveness estimates were measured based on the tools' performance but also indirectly, using the disability-adjusted life years. A decision tree was designed in TreeAge Healthcare Pro 2016, combined with a Markov model representing the natural history of cutaneous leishmaniasis. In addition to a deterministic analysis, univariate sensitivity and probabilistic analyses were performed to test the robustness of the results. RESULTS: If the tools are compared at the National Malaria and Leishmaniasis Control Program level in a period of low incidence, microscopy remains the preferred option. LAMP becomes more appropriate during cutaneous leishmaniasis seasons or outbreaks when its capacity to process several tests (e.g. up to 48) at a time can be maximised. RDT has a cost similar to microscopy when used at the reference clinic but as it is relatively easy to use, it could be implemented at the peripheral level, which would become cheaper than employing microscopy at the reference clinic. Moreover, combining RDT with microscopy or LAMP at the reference clinic for the negative suspects is economically more interesting than directly performing LAMP or microscopy respectively on all cutaneous leishmaniasis suspects at the reference clinic. CONCLUSIONS: When taking advantage of their respective strengths, LAMP and RDT can prove to be cost-effective alternatives to using microscopy alone at the reference clinic.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Cutaneous Type of study: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia Language: En Journal: Appl Health Econ Health Policy Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2019 Document type: Article Affiliation country: Spain Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmaniasis, Cutaneous Type of study: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia Language: En Journal: Appl Health Econ Health Policy Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2019 Document type: Article Affiliation country: Spain Country of publication: New Zealand